Home › Research › Risk genes beyond APOE
Genetic Insights into Alzheimer's Disease from Cuban American Studies
Larry Deon Adams, Jose J. Sanchez, Vanessa C. Rodriguez, Nicholas Gomez, Kara L. Hamilton‐Nelson, Glenies S Valladares, Sabrina M. Mas, Concepcion Silva‐Vergara et al.. Alzheimer s & Dementia, 2025-12-01
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Abstract Background Genetic studies have identified more than 80 loci associated with Alzheimer disease (AD), with APOE recognized as a major risk factor. Understanding the complete genetic landscape representation across ancestries in Alzheimer disease (AD) studies is critical to advance our ability in solving AD for everyone. Cuban Americans have a substantial European ancestral background alongside African and Amerindian ancestries. This study aims to determine whether these established AD risk loci Cuban Americans, which could enhance our understanding of the genetic architecture of AD. Methods The CA dataset includes TOPMED imputed data from 239 individuals (119 AD, 120 cognitively unimpaired) ascertained through the Cuban American Alzheimer's Disease Initiative (CuADI). For association analysis, we employed a mixed‐model regression approach (SAIGE) where we controlled for age, gender, population substructure (first three principal components), and relatedness. Results Association analysis in Cuban Americans replicated SORL1 (rs74685827), CR1 (rs6656401), ADAM17 (rs72777026), and RASGEF1C (rs113706587) as risk loci for AD with odds ratios of 5.71 ( p = 0.02), 1.70 ( p = 0.048), 1.81 ( p = 0.024), and 1.87 ( p = 0.032), respectively. Conversely, SPI1 (rs3740688) and ADAMTS1 (rs2830489) were found as protective loci with odds ratios of 0.60 ( p = 0.007) and 0.66 ( p = 0.049). Importantly, the APOE4 was significantly associated with AD (OR=2.94, p = 1.37×10 ‐4 ) showing an effect size similar to those observed in European populations. Conclusions This study replicated the associations of SORL1, CR1, ADAM17, RASGEF1C, SPI1 , and ADAMTS1 with AD risk and protection are found in Cuban Americans. The large effect of the APOE4 aligns with its established role in AD pathogenesis across different populations. These results enhance our overall understanding of the genetic underpinnings of AD and support the advancement of targeted research and therapeutic interventions.
What this study adds
Evidence grade: Low
The record lists 239 participants. In 239 Cuban American individuals, this study replicated SORL1, CR1, ADAM17 and RASGEF1C as risk loci for Alzheimer's disease and found SPI1 and ADAMTS1 as protective loci, with APOE4 also significantly associated. Reported effect size: OR=2.94.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Adams, L. D., Sanchez, J. J., Rodriguez, V. C., Gomez, N., Hamilton‐Nelson, K. L., Valladares, G. S., et al. (2025). Genetic Insights into Alzheimer's Disease from Cuban American Studies. Alzheimer s & Dementia. https://doi.org/10.1002/alz70855_106251
Vancouver
Adams LD, Sanchez JJ, Rodriguez VC, Gomez N, Hamilton‐Nelson KL, Valladares GS, et al. Genetic Insights into Alzheimer's Disease from Cuban American Studies. Alzheimer s & Dementia. 2025. doi:10.1002/alz70855_106251. PMID: 41442102.
BibTeX
@article{adams2025-41442102,
author = {Adams, Larry Deon and Sanchez, Jose J. and Rodriguez, Vanessa C. and Gomez, Nicholas and Hamilton‐Nelson, Kara L. and Valladares, Glenies S and Mas, Sabrina M. and Silva‐Vergara, Concepcion and others},
title = {{Genetic Insights into Alzheimer's Disease from Cuban American Studies}},
journal = {Alzheimer s \& Dementia},
year = {2025},
doi = {10.1002/alz70855_106251},
pmid = {41442102},
url = {https://doi.org/10.1002/alz70855_106251}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Abstract Background Genetic studies have identified more than 80 loci associated with Alzheimer disease (AD), with APOE recognized as a major risk factor.
- Results Association analysis in Cuban Americans replicated SORL1 (rs74685827), CR1 (rs6656401), ADAM17 (rs72777026), and RASGEF1C (rs113706587) as risk loci for AD with odds ratios of 5.71 ( p = 0.02), 1.70 ( p = 0.048), 1.81 ( p = 0.024), and 1.87 ( p = 0.032), respectively.
- Importantly, the APOE4 was significantly associated with AD (OR=2.94, p = 1.37×10 ‐4 ) showing an effect size similar to those observed in European populations.
- These results enhance our overall understanding of the genetic underpinnings of AD and support the advancement of targeted research and therapeutic interventions.
Why it matters
In 239 Cuban American individuals, this study replicated SORL1, CR1, ADAM17 and RASGEF1C as risk loci for Alzheimer's disease and found SPI1 and ADAMTS1 as protective loci, with APOE4 also significantly associated. These are genetic association findings that may inform risk understanding but do not treat or prevent the disease.
New to this subject? Start with our plain-English guide: Genetics →
Study details
- Participants239
- Effect sizeOR=2.94
- Evidence strengthLow
How this study scored 38/100
Published in a peer-reviewed journal. Scored zero for study design and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Alzheimer s & Dementia) |
| Journal's citation record | 2 / 4 | Alzheimer s & Dementia: journal h-index 228 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 2 / 4 | 239 participants |
| Effect reported | 3 / 3 | Effect reported with a statistic (interval, p-value, ratio or similar) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 0 / 7 | Cited 0 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.0 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 0 / 6 | Cited 0.0× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 0 / 4 | Last-listed author Margaret Pericak‐Vance: h-index 3 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | University of Miami: institution h-index 998 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 2 institution(s) in 2 countries |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 41442102) |
| Free to read | 2 / 2 | Free to read |
| Total | 38 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1002/alz70855_106251
- PubMed: 41442102
- Original source →
- Free full text: Alzheimer s & Dementia →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Risk genes beyond APOE from nearby years
Also in Risk genes beyond APOE
103 studies in the library are filed under Risk genes beyond APOE with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Risk genes beyond APOE hub.